Guren, Tormod Kyrre
Thomsen, Maria
Kure, Elin H
Sorbye, Halfdan
Glimelius, Bengt
Pfeiffer, Per
Österlund, Pia
Sigurdsson, Fridbjörn
Lothe, Inger Marie Bowitz
Dalsgaard, Astrid Marie
Skovlund, Eva
Christoffersen, Thoralf
Tveit, Kjell Magne
Article History
Received: 24 January 2017
Revised: 13 March 2017
Accepted: 15 March 2017
First Online: 11 April 2017
Competing interests
: HS declared grants and personal fees from Novartis, Ipsen, Amgen, Merck, and Nordic Drugs, and personal fees from Celgene, Bayer, Roche, and Pfizer. PÖ declared grants and personal fees from Roche, Merck, Sanofi Oncology, Amgen, Bayer, Eli Lilly, and Nordic Drugs, and personal fees from Baxalta/Shire. The remaining authors declare no conflict of interest.